Disputes Between South Korean Local Drug Makers And Multinationals Increasing, Expected To Get Worse
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Patent disputes between South Korean pharmaceutical companies and multinational companies are on the rise as locals try to produce generics of products approaching their patent expiration dates, according to a government report